Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Trends in Genetics : TIG|May 17, 2022
A new Down syndrome rat model races forwardRandall J Roper, Charles R Goodlett
Progress in Brain Research|February 15, 2020
Influence of allelic differences in Down syndromeRandall J Roper, Laura Hawley, Charles R Goodlett
Molecular Genetics & Genomic Medicine|September 26, 2017
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficitsMegan Stringer, Charles R Goodlett, Randall J Roper
Current Protocols in Mouse Biology|August 12, 2020
Behavioral Phenotyping for Down Syndrome in MiceRandall J Roper, Charles R Goodlett, María Martínez de Lagrán, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2026
Loss of DYRK1A ortholog mbk-1 impairs locomotor behavior in Caenorhabditis elegansElysabeth Otte, Emma Bratch, Alexandria Robbins, et al.
Pharmacology, Biochemistry, and Behavior|September 13, 2015
Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse modelMegan Stringer, Irushi Abeysekera, Karl J Dria, et al.
Scientific Reports|June 28, 2020
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome miceCharles R Goodlett, Megan Stringer, Jonathan LaCombe, et al.
Neurobiology of Disease|November 22, 2023
Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse modelLaura E Hawley, Megan Stringer, Abigail J Deal, et al.
Complementary Therapies in Medicine|July 24, 2019
Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndromeRachel Long, Montana L Drawbaugh, Charlene M Davis, et al.
Pageof 9